Tenaya Therapeutics (TNYA) Other Non-Current Assets (2020 - 2026)

Tenaya Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 21.36% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (down 21.36% YoY), while the FY2025 annual figure was $4.2 million, down 11.85% from the prior year.
• Other Non-Current Assets was $3.8 million for Q1 2026 at Tenaya Therapeutics, down from $4.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $5.7 million in Q3 2023 to a low of $399000.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $4.5 million across 5 years, with a median of $4.8 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets dropped 27.06% in 2022, then surged 1060.4% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $4.8 million in 2022, then climbed by 18.44% to $5.7 million in 2023, then retreated by 15.15% to $4.8 million in 2024, then fell by 11.85% to $4.2 million in 2025, then decreased by 10.86% to $3.8 million in 2026.
• The last three Other Non-Current Assets figures came in at $3.8 million (Q1 2026), $4.2 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.